CPT® Code 95939

Quick Reference

• Code definition: Diagnostic study of the central (cortical) motor pathway via transcranial electrical stimulation of the motor cortex, with recording from peripheral muscles in both upper and lower limbs in a single session.
• Key billing rule: MUE = 1 per date of service (rationale: Code Descriptor/CPT Instruction); the code's own descriptor defines it as covering both limb groups, so it can only be billed once regardless of how many muscles or repetitions are recorded [2].
• Modifier essentials: Modifier 26 applies when the physician provides interpretation only in a facility or lab setting; Modifier TC applies when billing for the technical component alone. PC/TC Indicator = 1 confirms this split is standard [1]. Modifier 50 does not apply; bilateral adjustment is excluded per CMS policy.
• Documentation must-have: A written physician report is required by the CPT descriptor; it must document stimulation parameters, muscles tested bilaterally (upper and lower), MEP amplitude and latency, CMCT calculation, CMAP comparison, and clinical interpretation. Missing or incomplete reports are the primary denial trigger [3].
• Top confusion point: 95939 tests the central motor (corticospinal) pathway only. It is not interchangeable with 95938, which tests the somatosensory (sensory) pathway via peripheral nerve stimulation, a physiologically distinct service.
• Payer alert: 95941 is not valid for Medicare purposes. Do not substitute 95939 for intraoperative monitoring codes or vice versa.

When to Use This Code

95939 captures a comprehensive, bilateral central motor pathway evaluation in a single outpatient or laboratory encounter. Use it when transcranial stimulation of the motor cortex is performed and responses are recorded from muscles in both the upper and lower extremities in the same session.

Clinical indications include:

• Multiple sclerosis (G35) with suspected corticospinal tract demyelination affecting all four extremities
• Amyotrophic lateral sclerosis (G12.21) requiring quantification of upper motor neuron involvement
• Hereditary spastic paraplegia (G11.4) and other corticospinal tract degenerations
• Cervical or thoracic myelopathy (M50.00) where clinical findings suggest bilateral motor pathway compromise
• Post-traumatic assessment following spinal cord injury or traumatic brain injury affecting motor function
• Pre-surgical baseline documentation when the planned intervention may impact central motor pathways

Scope boundaries: The code requires both upper and lower limb recordings in the same encounter. If the clinical indication supports upper limb testing only, use 95928. If lower limb only, use 95929. 95939 is not a timed code; there is no per-unit billing based on minutes or number of muscles tested.

Setting: Commonly performed in hospital outpatient neurophysiology labs, independent diagnostic testing facilities, and neurology offices with in-house equipment. The PC/TC split makes 95939 particularly relevant in settings where the performing technologist and interpreting physician bill separately [1].

Code Differentiation Table

The single most critical differentiator: 95939 tests the descending motor pathway (cortex to muscle via the corticospinal tract) using transcranial stimulation. 95938 tests the ascending sensory pathway (peripheral nerve to cortex via dorsal columns) using peripheral nerve stimulation. These are physiologically distinct studies and may be reported together on the same date when both are clinically performed and documented [3].

flowchart TD
    A[Evoked potential study ordered] --> B{Motor or sensory pathway?}
    B --> |Motor: transcranial cortex stimulation| C{Which limbs tested?}
    B --> |Sensory: peripheral nerve stimulation| D{Which limbs tested?}
    C --> |Upper only| E[95928]
    C --> |Lower only| F[95929]
    C --> |Both upper and lower| G[95939]
    D --> |Upper only| H[95925]
    D --> |Lower only| I[95926]
    D --> |Both upper and lower| J[95938]

Billing & Modifier Rules

Modifier 26 / TC split: 95939 carries PC/TC Indicator = 1, confirming the professional and technical components may be billed separately [1].

• Append Modifier 26 when the physician reviews recordings and produces the written interpretation report without providing the technical service. 2026 RVUs with Modifier 26: Work 2.19, PE 1.24, MP 0.09, Total 3.52.
• Append Modifier TC when billing for equipment, recording supplies, and technologist time only. 2026 RVUs with TC: Work 0.00, PE 14.06, MP 0.06, Total 14.12.
• In non-facility settings where the physician owns the equipment and performs both components, bill globally without a modifier.

Modifier 50 does not apply. CMS Bilateral Surgery indicator = 2 for 95939, meaning the 150% bilateral payment adjustment does not apply. The code by definition covers both sides of the body; no bilateral modifier is appropriate [1].

Modifier 59 considerations: When 95939 and 95938 are billed on the same date (MEP plus SEP), Modifier 59 may be required to bypass NCCI edit pairs. Because these are distinct physiological pathways, the services are separately reportable when both are performed and documented. Verify in current NCCI PTP edit tables before submission.

Modifier 52 (Reduced Services): Do not append Modifier 52 to 95939 when only upper or lower limbs were tested. The correct action is to recode to 95928 or 95929. Modifier 52 is for partially reduced services within the scope of the billed code, not for selecting the wrong code.

MUE = 1: CMS has established a medically unlikely edit of 1 unit per date of service [2]. The rationale is "Code Descriptor/CPT Instruction," meaning the code's own language limits it to one comprehensive bilateral study per encounter. Billing more than 1 unit will be denied at the claim level.

Add-on codes: 95940 and 95941 are intraoperative monitoring add-on codes listed separately in addition to a primary surgical procedure. The CPT codebook cross-references them with 95939 only in the context of IONM permitted companion codes. Do not append these to 95939 as supplemental outpatient billing.

Documentation Essentials

The CPT descriptor explicitly requires a physician-generated written report [3]. This is not optional; it is a component of the code's definition. The report must contain:

• Patient identification and ordering indication: clinical diagnosis or symptom prompting the study
• Technical parameters: electrode placement sites, impedance values, and scalp stimulation location for each muscle tested
• Muscles tested per limb group: upper extremity muscles (e.g., biceps, triceps, abductor pollicis brevis, abductor digiti minimi) and lower extremity muscles, including whether ipsilateral and contralateral upper extremities were both evaluated
• MEP measurements: amplitude and onset latency for each muscle, compared to baseline nerve conduction studies performed as part of the encounter
• CMCT (central motor conduction time): calculated from each muscle's data
• CMAP comparison: MEP amplitude expressed as a percentage of compound muscle action potential amplitude, with ulnar nerve stimulation methodology documented for abductor digiti minimi
• Cortical silent period analysis: dissociation between MEP threshold and cortical stimulation silent period, including stimulator output increments tested
• Clinical interpretation: the physician's assessment of motor pathway integrity based on the recorded data

Audit red flags specific to 95939:

• Documentation referencing only upper extremity muscles with no lower extremity data, indicating 95928 should have been billed
• Boilerplate or templated reports lacking patient-specific waveform values
• Absence of CMCT calculation or CMAP comparison, both of which are described procedure components
• Missing documentation of baseline nerve conduction studies, which the CPT description identifies as a prerequisite to MEP recording
• Interpretation signed by someone who did not review the actual recordings

Medical necessity: No National Coverage Determination exists for central MEP studies. Coverage is governed by MAC Local Coverage Determinations, which were not retrievable at the time of this writing. The ordering documentation must establish why central motor pathway evaluation is clinically necessary based on the patient's neurological presentation; documentation of prior inconclusive workup (e.g., MRI, NCS/EMG) may be required by some MACs.

Medicare, Commercial & Medicaid Payer Rules

Medicare:

95939 is an active Medicare code with Type of Service = 5 (Diagnostic Laboratory) [1]. No NCD governs coverage; MAC LCDs apply and vary by jurisdiction. Coverage criteria typically require a neurological indication suggesting corticospinal pathway dysfunction. Verify with the applicable MAC before billing.

MUE = 1 per date of service [2]. APC Status Indicator = "Procedure or Service, Not Discounted when Multiple," meaning that when 95939 is billed with other separately payable services in the hospital outpatient setting, no multiple procedure discount applies.

95941 is not valid for Medicare purposes and should never be substituted for or billed alongside 95939 in a Medicare claim [1].

Global Days = XXX, meaning the global concept does not apply. Pre- and post-procedure services are not bundled into the code's payment.

Commercial payers:

Commercial payers generally follow CPT conventions for MEP code selection but may require prior authorization for neurophysiology studies depending on the clinical indication and plan. No specific commercial payer policies for 95939 were confirmed in the research document. Verify prior authorization requirements before scheduling for commercial patients.

Common Denials & Prevention

Missing or incomplete written report

The CPT descriptor makes a physician-written report a required component of 95939. Payers deny claims when the record contains raw waveform data without a signed interpretation, or when a report exists but lacks specific measurements such as CMCT and CMAP comparison. Prevention: establish a standard report template covering all required elements before billing is submitted, and confirm the interpreting physician has signed.

Upcoding: billing 95939 when only one limb group was tested

Auditors look for documentation that corroborates both upper and lower limb recordings. When the procedure report mentions only upper extremity muscles with no reference to lower extremity electrode placement or recordings, the claim is vulnerable to denial and recoupment as upcoding. Prevention: code based on what the procedure report documents. If lower extremities were not studied, bill 95928; if upper extremities were not studied, bill 95929.

Unbundling: reporting 95928 plus 95929 instead of 95939

Billing both component codes when a comprehensive bilateral study was performed misrepresents the service and may be flagged as unbundling. When both limb groups appear in the procedure report for the same encounter, 95939 is the correct code [3].

MUE denial: billing more than 1 unit

Billing 95939 with units of 2 or more will be denied at the claim level per MUE = 1 [2]. This applies regardless of the number of muscles, repetitions, or sessions documented within the encounter. Prevention: bill 1 unit.

Code substitution: using 95939 for intraoperative monitoring

95939 is a diagnostic outpatient procedure, not an intraoperative monitoring code. For intraoperative MEP monitoring, use 95940 (in-person, per 15 minutes) listed as an add-on to the surgical procedure code. Using 95939 in the operative setting constitutes miscoding and will not survive audit.

Coding Scenarios

Scenario 1: MS patient, bilateral MEP evaluation, facility setting

A 47-year-old with relapsing-remitting multiple sclerosis (G35) presents to a hospital outpatient neurophysiology lab for central motor pathway evaluation. A technologist performs baseline NCS and MEP recordings from bilateral upper and lower extremity muscles. The attending neurologist reviews all waveform data and produces a signed written report.

Correct coding: Facility bills 95939-TC; physician bills 95939-26, diagnosis G35.

Why: Both upper and lower limbs were tested, justifying 95939 over the component codes. The PC/TC split applies because the lab owns the equipment and the physician provided interpretation only.

Scenario 2: Myelopathy evaluation, upper limbs only

A 61-year-old with cervical disc disease at C5-C6 presenting with hand weakness and reduced grip. The ordering neurologist limits the MEP study to upper extremity muscles because lower extremity function is clinically intact.

Correct coding: 95928, diagnosis M50.00.

Why: Documentation supports upper limb testing only. Billing 95939 would constitute upcoding. Code selection follows the limbs actually studied in the procedure report.

Scenario 3: Combined MEP and SEP studies for ALS evaluation

A neurologist orders both motor and somatosensory evoked potential studies on a patient with suspected ALS (G12.21). The MEP study evaluates corticospinal tract integrity and the SEP study evaluates dorsal column function. Both upper and lower limbs are tested for each modality.

Correct coding: 95939 (central MEP, upper and lower) and 95938 (SEP, upper and lower), diagnosis G12.21. Append Modifier 59 to 95938 if NCCI edit review indicates it is required.

Why: 95939 and 95938 test physiologically distinct pathways and are separately reportable when both are performed and documented.

Scenario 4: Intraoperative spinal surgery monitoring

A neurophysiology team monitors a patient's motor pathways continuously during a lumbar decompression using transcranial stimulation and lower extremity MEP recordings for 90 minutes.

Correct coding: 95940 x 6 units (each 15-minute interval), listed in addition to the surgical procedure code.

Why: Intraoperative continuous monitoring requires the IONM add-on code, not 95939. Using 95939 in the operative setting constitutes miscoding; 95939 is a diagnostic outpatient study, not a monitoring service.

Related Codes

• 95928: Central MEP study, upper limbs only. Use when lower extremities are not tested.
• 95929: Central MEP study, lower limbs only. Use when upper extremities are not tested.
• 95925: Short-latency SEP, upper limbs. Somatosensory pathway; separately reportable from MEP codes.
• 95926: Short-latency SEP, lower limbs. Somatosensory pathway; separately reportable from MEP codes.
• 95938: Short-latency SEP, upper and lower limbs. Tests sensory pathway; may be reported same date as 95939 when both modalities are clinically performed.
• 95940: Continuous intraoperative neurophysiology monitoring, OR, per 15 minutes. Add-on code for surgical IONM; not a diagnostic study.
• 95941: Continuous IONM, remote or outside OR, per hour. Add-on; not valid for Medicare purposes.

Sources {#sources}

1. CMS 2026 National Physician Fee Schedule Relative Value File, January Release — RVU values, PC/TC indicator, bilateral surgery indicator, and status indicators for 95939 and related codes (released 12/29/2025).
2. CMS MUE Practitioner Services File, Effective 04-01-2026 — MUE = 1 for 95939, rationale: Code Descriptor/CPT Instruction.
3. AMA CPT Code Descriptor, 95939 — Official descriptor confirming required procedure components including written physician report; code added 2012, medium descriptor updated 2013.